National Pension Service decreased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 6.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 103,800 shares of the biotechnology company's stock after selling 6,900 shares during the period. National Pension Service owned about 0.14% of Axon Enterprise worth $41,478,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also modified their holdings of AXON. Quent Capital LLC lifted its stake in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company's stock worth $32,000 after acquiring an additional 75 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company's stock worth $27,000 after purchasing an additional 79 shares during the last quarter. Friedenthal Financial acquired a new position in shares of Axon Enterprise during the third quarter worth $51,000. Reston Wealth Management LLC purchased a new position in Axon Enterprise in the third quarter valued at $60,000. Finally, Asset Dedication LLC acquired a new stake in Axon Enterprise in the second quarter valued at $47,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Axon Enterprise Stock Performance
NASDAQ AXON traded up $9.23 during trading hours on Thursday, hitting $468.75. 830,757 shares of the stock were exchanged, compared to its average volume of 522,576. Axon Enterprise, Inc. has a 12-month low of $212.88 and a 12-month high of $471.00. The stock has a 50-day moving average of $407.26 and a 200 day moving average of $343.94. The company has a market cap of $35.42 billion, a price-to-earnings ratio of 121.25, a price-to-earnings-growth ratio of 10.99 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analysts' expectations of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The company's quarterly revenue was up 34.5% compared to the same quarter last year. During the same period last year, the firm earned $0.80 EPS. As a group, equities research analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company's stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the transaction, the director now directly owns 26,259 shares in the company, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the company's stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the sale, the director now owns 26,259 shares of the company's stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 4,767 shares of Axon Enterprise stock in a transaction on Thursday, October 3rd. The stock was sold at an average price of $404.14, for a total value of $1,926,535.38. Following the transaction, the chief executive officer now directly owns 2,925,060 shares of the company's stock, valued at $1,182,133,748.40. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 371,172 shares of company stock valued at $137,000,162. 5.70% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
AXON has been the subject of several recent analyst reports. Robert W. Baird upped their price target on Axon Enterprise from $440.00 to $460.00 and gave the company an "outperform" rating in a report on Monday. Bank of America initiated coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a "buy" rating and a $380.00 target price on the stock. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a research report on Thursday, October 31st. Finally, Northland Securities boosted their target price on Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a report on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $392.85.
Get Our Latest Analysis on Axon Enterprise
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.